DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 5.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 51.7128503489. According to RSI analysis, divislab is at it's support. 8 DIVISLAB RSI Chart
MACD (?) MACD: 11.2672693202 and Signal Line: 11.373453864. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0 DIVISLAB MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, divislab is facing resistance from it's 20-day simple moving average at 1727.222 and support level is at 1.69e+03. 2 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 1720.843, 1692.377, 1606.524. 10.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.474. 5.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1710.9714 and 1684.15. Resistance level is 1797.8. 6.5 DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 47.5 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 19.7 which means DIVISLAB is in a trading range and there is no trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 21, 2019
Open Price 1763.55
High Price 1779.95
Low Price 1740.1
Close Price 1747.05
Absolute Change -16.55
Percentage Change -0.938%
Weekly Change 5.47%
Monthly Change 0.674%
Yearly Change 12.8%
52-week high 1797.8
52-week low 1420.0
Corporate Actions
ExDate Purpose
August 14, 2019 AGM/DIV- RS 16 PER SH
August 31, 2018 AGM/DIV-RS 10 PER SHARE
September 15, 2017 AGM/DIV-RS 10/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.606
Confidence in Beta2.7%
Market Capital Rs. 46378.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 41.9
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 21 November 2019: Deliverable Quantity:1.46e+05 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 21 November 2019: Daily Volatility:0.3229 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 21 November 2019: PCR_OI:0.442 PCR:0.298 NA DIVISLAB PCR Chart
Option Pain (?) 21 November 2019: Max Pain:1700.0 NA DIVISLAB Option Pain Chart
Premium (?) 21 November 2019 Premium: 2.2 Futures OI:2499200.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 21 November 2019: Price:1747.05 Put with maximum OI:1700.0 Call with maximum OI:1800.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 28, 2019 1749.25 2499200.0 1905.0 1905.0 1747.05
December 26, 2019 1757.0 144800.0 229.0 229.0 1747.05
January 30, 2020 1770.0 9200.0 17.0 17.0 1747.05

Announcements

April 09, 2018 DrDisc. under Reg.30 of SEBI (SAST) Reg.2011r. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
November 01, 2017 DiOutcome of Board Meetingivi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 25, 2019 November 05, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
August 01, 2019 August 10, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

DIVISLAB is part of...

Index Weightage
CNXPHARMA NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play